Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Can You Freeze Stem Cells? A Patient’s Guide to Stem Cell Cryopreservation

Written by Dr. David Greene, MD, PhD, MBA on May 20, 2026

Table of Contents

If you’re researching stem cell therapy, you’ve likely encountered questions about how these cells are stored — and whether freezing them affects their effectiveness. It’s a reasonable concern. After all, biological material seems fragile, and the idea of freezing and thawing living cells raises natural questions about quality and safety.

The short answer is: yes, stem cells can absolutely be frozen — but how they’re frozen makes all the difference. This article explains the science of stem cell cryopreservation in plain language, what patients should understand before choosing a provider, and what the evidence says about frozen versus fresh cell preparations.

What Is Cryopreservation?

Cryopreservation is the process of cooling biological material — in this case, stem cells — to very low temperatures to halt metabolic activity and preserve the cells for future use. When done correctly, the cells can be stored for extended periods (months to years) and remain viable after thawing.

This technology has been used safely in medicine for decades. It underpins blood banking, sperm and egg freezing for fertility treatments, and bone marrow transplantation programs worldwide. To understand the broader context of how stem cell therapy works, it helps first to understand how cells are processed and preserved before they ever reach a patient.

Why You Can't Simply Freeze Stem Cells Without Protection

This is a critical point that many patients don’t realize: you cannot freeze stem cells in plain solution and expect them to survive.

When water inside a cell freezes, it forms ice crystals. These crystals expand, puncture the cell membrane, and destroy the cell. The result is a viability rate of essentially zero. The cells are dead before they can ever be administered to a patient.

This is why a cryoprotectant is an essential component of any legitimate stem cell freezing protocol. It’s one of several quality factors patients should evaluate when choosing a regenerative medicine clinic.

What Is a Cryoprotectant?

A cryoprotectant is a substance added to the cell suspension before freezing that prevents ice crystal formation within and around the cells. The most widely used cryoprotectant in clinical and research settings is dimethyl sulfoxide (DMSO), often used in combination with human serum albumin or other stabilizing agents.

Cryoprotectants work by:

Replacing water inside the cell, reducing the volume available for ice crystal formation

Lowering the freezing point of the solution

Protecting cell membranes during the temperature transition

According to published research in cell biology and biobanking, the use of validated cryoprotectant formulations is considered the industry standard for any clinical-grade cell therapy product. This is true whether you’re working with umbilical cord stem cells, bone marrow-derived cells, or adipose tissue-derived stem cells.

What Temperature Are Stem Cells Stored At?

Temperature consistency during storage is just as important as the freezing process itself. The accepted standard in regenerative medicine is:

Storage Method

Temperature

Notes

Ultra-low freezer

−80°C

Suitable for short- to medium-term storage

Liquid nitrogen (vapor phase)

−150°C to −180°C

Preferred for long-term storage

Liquid nitrogen (liquid phase)

−196°C

Maximum cold; used in research and biobanking

At these temperatures, all biochemical processes — including degradation — are effectively stopped. Cells stored properly at −80°C or below can maintain viability for months to years when the cold chain is uninterrupted.

What Viability Should You Expect After Thawing?

Viability refers to the percentage of cells that are alive and functional after the freeze-thaw cycle. This is a key quality metric for any stem cell product, and an important consideration when evaluating the benefits of stem cell therapy for your specific condition.

Research and clinical experience in the field suggest that well-optimized cryopreservation protocols can preserve 70–90%+ cell viability after thawing, depending on the cell type, the cryoprotectant formula, the controlled-rate freezing method used, and storage duration.

At R3 Stem Cell, the cryopreservation protocols used for their biologics are reported to yield post-thaw viability rates ranging from 90% to 96% — a figure consistent with high-quality processing standards when validated laboratory methods are applied correctly. Patients considering any stem cell provider should ask specifically about post-thaw viability testing, as this data is a meaningful indicator of product quality.

Fresh vs. Frozen Stem Cells: Does It Matter?

One debate in the regenerative medicine community concerns whether fresh (never frozen) stem cells outperform cryopreserved cells after thawing. R3 Stem Cell has published a detailed comparison of fresh versus frozen stem cells for patients who want to explore this topic in depth. The evidence is nuanced.

Some laboratory studies have observed that freshly processed cells may show slightly higher initial metabolic activity compared to their thawed counterparts. However, other research — including clinical studies involving mesenchymal stem cell (MSC) therapies — has found no significant difference in clinical outcomes between fresh and properly cryopreserved cell preparations.

The critical factors appear to be:

Quality of the source material (donor health, tissue type)

Processing technique (GMP-compliant lab standards)

Cryoprotectant formulation and concentration

Controlled-rate freezing (gradual cooling vs. rapid freezing)

Thawing protocol (rapid rewarming is generally preferred)

In short, a well-cryopreserved stem cell product from a quality-controlled laboratory is clinically comparable to a fresh preparation — and in many real-world scenarios, cryopreservation offers practical advantages, including quality testing before release, logistics, and scheduling flexibility. Understanding the advantages of mesenchymal stem cells in regenerative medicine can help patients make more informed decisions about their treatment options.

Is Freezing Stem Cells Legally and Regulatorily Permitted?

Yes. In the United States, the storage and use of human cell and tissue-based products (HCT/Ps) — including cryopreserved stem cells — is regulated by the FDA under 21 CFR Part 1271. For a thorough overview of how these rules apply to regenerative biologics, see R3’s detailed guide on FDA regulations for human cell and tissue-based products.

Cryopreservation itself is a well-established and fully permitted practice within this regulatory framework, provided the product is properly processed and used in an appropriate clinical context. Patients can also review the relationship between stem cells and the FDA for additional context on how oversight works in practice.

Patients should always verify that any provider they’re considering operates under FDA-compliant protocols and uses clinically tested, properly labeled biologic products. It’s also worth understanding whether stem cell therapy is legal in the US and what that means for your treatment options.

How Cryopreservation Supports Real-World Regenerative Therapy

One practical but underappreciated benefit of cryopreservation is what it enables logistically. Because cells can be stored and released only after passing quality testing, cryopreservation actually improves safety compared to same-day processing in many scenarios. It allows:

Pre-release sterility and viability testing before any product reaches a patient

Flexible scheduling so treatment isn't dependent on same-day cell processing

Consistent dosing because cell counts can be standardized before freezing

Geographic distribution to treatment centers without on-site processing labs

This is particularly relevant for understanding how regenerative therapies work across a wide network of clinical locations, and why regenerative medicine differs from other forms of treatment in both philosophy and practice.

How R3 Stem Cell Approaches Cryopreservation

R3 Stem Cell, led by founder and CEO Dr. David Greene, operates across more than 70 centers in seven countries and uses cryopreserved biologics as part of their regenerative medicine protocols. Their scientific team uses cryoprotectant-based preservation methods with storage at −80°C or below, with reported post-thaw viability consistently in the 90–96% range.

R3 currently offers FDA 361-compliant Wharton’s Jelly umbilical cord allograft as one of their primary biologics, processed under strict quality controls. Their approach addresses many of the common myths about external-source regenerative biologics that patients encounter online.

Patients interested in learning whether stem cell therapy may be appropriate for their condition can explore what to expect from stem cell therapy or review R3’s stem cell therapy FAQ before requesting a free consultation to speak with a provider about candidacy for treatment.

Summary

Freezing stem cells is not only possible — it’s a cornerstone of modern regenerative medicine when done correctly. The key requirements are:

Use a validated cryoprotectant to prevent ice crystal damage

Store at appropriate ultra-low temperatures (−80°C or colder)

Follow controlled thawing protocols to maximize post-thaw viability

Work with GMP-compliant laboratories that conduct viability testing

Patients evaluating stem cell therapy providers should treat post-thaw viability data and regulatory compliance as baseline expectations — not bonus features. These are the foundational indicators of a safe, high-quality product. If you’re still in the research phase, reviewing the benefits of regenerative medicine and who can benefit from regenerative medicine are good next steps before consulting with a specialist.

Contact Us

Why Dr. Hector is "Passionate" About the Word "Natural"

Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes:

What Does the Bioethics Community Say?